Funding for this research was provided by:
Cancer Australia (NA)
Received: 20 February 2019
Accepted: 19 August 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: This study did not require ethics approval as determined by the NSW Health policy directive (Quality Improvement & Ethical Review: A Practice Guide for NSW, available from: ExternalRef removed).
: This study did not require consent to participate. Waiver approval from aninstitution/committee was not sought. The NSW Health Records and Information Privacy Act 2002 (HRIPA) recognises that an organisation’s quality improvement activities do not require explicit patient consent additional to that elicited in the original clinical practice interaction. This is stated in the NSW Health policy directive (Quality Improvement & Ethical Review: A Practice Guide for NSW, available from: ExternalRef removed).
: The NSWCR received financial support from Cancer Australia which provided additional resources for the collection of RD-stage data as part of an initiative to improve national reporting of cancer stage, treatment and recurrence (STaR).